Antonenko, S.V., and G.D. Telegeev. “Inhibition of USP1, a New Partner of Bcr-Abl, Results in Decrease of Bcr-Abl Level in K562 Cells”. Experimental Oncology 42, no. 2 (June 1, 2023): 109–114. Accessed June 27, 2026. https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-10.